This is also in line with various studies demonstrating cell-cycle-associated regulation of cancer; consequently, cell-cycle inhibitors like FOXF1 might be considered as a therapeutic target in the management of cancer [46,47,48]. The gene discussed is FOXF1; the disease is cancer.